Kayla Atchison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kayla Atchison has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Zahra Goodarzi
University of Calgary
7 shared publications Zahinoor Ismail
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada; Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada
4 shared publicationsDallas Seitz
Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada
2 shared publicationsDelaney Ewert
Department of Community Health Sciences, University of Calgary , Calgary, Alberta , Canada
2 shared publicationsJennifer A. Watt
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
2 shared publications- Jennifer Ann Watt
University of Toronto, Toronto, Ontario, Canada (Y.Q.H., J.W.)
2 shared publications
Latest Publications
- Open Access
- 28 August 2025
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (10) , 105791
Creating a Clinical Care Pathway for Depressive Symptoms and Disorders in Long-Term Care: A Modified Delphi Process
- 28 August 2025
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (10) , 105791
Open AccessCreating a Clinical Care Pathway for Depressive Symptoms and Disorders in Long-Term Care: A Modified Delphi Process
- Open Access
- 11 April 2025
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (6) , 105435
Treatments for Depression for Older Adults Living in Long-Term Care: A Systematic Review and Network Meta-Analysis
- 11 April 2025
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 26 (6) , 105435
Open AccessTreatments for Depression for Older Adults Living in Long-Term Care: A Systematic Review and Network Meta-Analysis
- Open Access
- 11 November 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (11) , e70058
Depression detection in dementia: A diagnostic accuracy systematic review and meta analysis update
Background: Depression is common in persons with dementia and is often under‐detected and under‐treated. It is critical to understand which available tools accurately detect depression in the context of dementia.Methods: We updated our systematic review completed in 2015. The search strategy of our original review was replicated in Medline, Embase, and PsycINFO. Studies describing the use of a tool to identify depression in persons with dementia, compared to a criterion standard, and reporting diagnostic accuracy outcomes were included in the review update. Pooled prevalence estimates of major depression and pooled estimates of diagnostic accuracy outcomes (i.e., sensitivity [SN], specificity [SP]) for tools were calculated.Results: Three studies were included of the 8980 returned from the database search and were added to the prior 20 articles from the 2015 review. The Cornell Scale for Depression in Dementia (CSDD), Geriatric Depression Scale (GDS)−15 item, Neuropsychiatric Inventory‐Depression items (NPI‐D), and Depression in Old Age Scale (DIA‐S) were evaluated in the three studies. Two new studies were added to the existing pooled prevalence estimate of major depression (29%, 95% confidence interval [CI] = 21.6%–36.5%, n = 17) and pooled diagnostic accuracy estimate for the CSDD at the best cut‐off (SN = 0.83, 95% CI = 0.74–0.90; SP = 0.81, 95% CI = 0.69–0.89). New pooled diagnostic accuracy estimates were completed for the CSDD (cut‐off ≥12) (SN = 0.61, 95% CI = 0.42–0.77; SP = 0.83, 95% CI = 0.76–0.88), GDS‐15 (best cut‐off) (SN = 0.65, 95% CI = 0.40–0.83; SP = 0.72, 95% CI = 0.55–0.85), and Montgomery Asberg Depression Rating Scale (MADRS) (best cut‐off) (SN = 0.77, 95% CI = 0.67–0.85; SP = 0.68, 95% CI = 0.60‐0.75).Conclusions: The CSDD continues to have the most evidence for depression case finding in persons living with dementia. The CSDD and Hamilton Depression Rating Scale have the highest sensitivities and may be recommended for use over other common tools like the GDS‐15 and MADRS. Newly identified tools like the NPI‐D and DIA‐S require further study before they can be recommended for use in practice.
- 11 November 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (11) , e70058
Open AccessDepression detection in dementia: A diagnostic accuracy systematic review and meta analysis update
Background: Depression is common in persons with dementia and is often under‐detected and under‐treated. It is critical to understand which available tools accurately detect depression in the context of dementia.Methods: We updated our systematic review completed in 2015. The search strategy of our original review was replicated in Medline, Embase, and PsycINFO. Studies describing the use of a tool to identify depression in persons with dementia, compared to a criterion standard, and reporting diagnostic accuracy outcomes were included in the review update. Pooled prevalence estimates of major depression and pooled estimates of diagnostic accuracy outcomes (i.e., sensitivity [SN], specificity [SP]) for tools were calculated.Results: Three studies were included of the 8980 returned from the database search and were added to the prior 20 articles from the 2015 review. The Cornell Scale for Depression in Dementia (CSDD), Geriatric Depression Scale (GDS)−15 item, Neuropsychiatric Inventory‐Depression items (NPI‐D), and Depression in Old Age Scale (DIA‐S) were evaluated in the three studies. Two new studies were added to the existing pooled prevalence estimate of major depression (29%, 95% confidence interval [CI] = 21.6%–36.5%, n = 17) and pooled diagnostic accuracy estimate for the CSDD at the best cut‐off (SN = 0.83, 95% CI = 0.74–0.90; SP = 0.81, 95% CI = 0.69–0.89). New pooled diagnostic accuracy estimates were completed for the CSDD (cut‐off ≥12) (SN = 0.61, 95% CI = 0.42–0.77; SP = 0.83, 95% CI = 0.76–0.88), GDS‐15 (best cut‐off) (SN = 0.65, 95% CI = 0.40–0.83; SP = 0.72, 95% CI = 0.55–0.85), and Montgomery Asberg Depression Rating Scale (MADRS) (best cut‐off) (SN = 0.77, 95% CI = 0.67–0.85; SP = 0.68, 95% CI = 0.60‐0.75).Conclusions: The CSDD continues to have the most evidence for depression case finding in persons living with dementia. The CSDD and Hamilton Depression Rating Scale have the highest sensitivities and may be recommended for use over other common tools like the GDS‐15 and MADRS. Newly identified tools like the NPI‐D and DIA‐S require further study before they can be recommended for use in practice.
- 2 July 2024
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 53 (7)
Detection of anxiety symptoms and disorders in older adults: a diagnostic accuracy systematic review
Anxiety symptoms and disorders are common in older adults and often go undetected. A systematic review was completed to identify tools that can be used to detect anxiety symptoms and disorders in community-dwelling older adults. MEDLINE, Embase and PsycINFO were searched using the search concepts anxiety, older adults and diagnostic accuracy in March 2023. Included articles assessed anxiety in community-dwelling older adults using an index anxiety tool and a gold standard form of anxiety assessment and reported resulting diagnostic accuracy outcomes. Estimates of pooled diagnostic accuracy outcomes were completed. Twenty-three anxiety tools were identified from the 32 included articles. Pooled diagnostic accuracy outcomes were estimated for the Geriatric Anxiety Inventory (GAI)-20 [n = 3, sensitivity = 0.89, 95% confidence interval (CI) = 0.70–0.97, specificity = 0.80, 95% CI = 0.67–0.89] to detect generalized anxiety disorder (GAD) and for the GAI-20 (n = 3, cut off ≥ 9, sensitivity = 0.74, 95% CI = 0.62–0.83, specificity = 0.96, 95% CI = 0.74–1.00), Beck Anxiety Inventory (n = 3, sensitivity = 0.70, 95% CI = 0.58–0.79, specificity = 0.60, 95% CI = 0.51–0.68) and Hospital Anxiety and Depression Scale (HADS-A) (n = 3, sensitivity = 0.78, 95% CI = 0.60–0.89, specificity = 0.76, 95% CI = 0.60–0.87) to detect anxiety disorders in clinical samples. The GAI-20 was the most studied tool and had adequate sensitivity while maintaining acceptable specificity when identifying GAD and anxiety disorders. The GAI-20, GAI-Short Form and HADS-A tools are supported for use in detecting anxiety in community-dwelling older adults. Brief, self-rated and easy-to-use tools may be the best options for anxiety detection in community-dwelling older adults given resource limitations. Clinicians may consider factors including patient comorbidities and anxiety prevalence when selecting a tool and cut off.
- 2 July 2024
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 53 (7)
Detection of anxiety symptoms and disorders in older adults: a diagnostic accuracy systematic review
Anxiety symptoms and disorders are common in older adults and often go undetected. A systematic review was completed to identify tools that can be used to detect anxiety symptoms and disorders in community-dwelling older adults. MEDLINE, Embase and PsycINFO were searched using the search concepts anxiety, older adults and diagnostic accuracy in March 2023. Included articles assessed anxiety in community-dwelling older adults using an index anxiety tool and a gold standard form of anxiety assessment and reported resulting diagnostic accuracy outcomes. Estimates of pooled diagnostic accuracy outcomes were completed. Twenty-three anxiety tools were identified from the 32 included articles. Pooled diagnostic accuracy outcomes were estimated for the Geriatric Anxiety Inventory (GAI)-20 [n = 3, sensitivity = 0.89, 95% confidence interval (CI) = 0.70–0.97, specificity = 0.80, 95% CI = 0.67–0.89] to detect generalized anxiety disorder (GAD) and for the GAI-20 (n = 3, cut off ≥ 9, sensitivity = 0.74, 95% CI = 0.62–0.83, specificity = 0.96, 95% CI = 0.74–1.00), Beck Anxiety Inventory (n = 3, sensitivity = 0.70, 95% CI = 0.58–0.79, specificity = 0.60, 95% CI = 0.51–0.68) and Hospital Anxiety and Depression Scale (HADS-A) (n = 3, sensitivity = 0.78, 95% CI = 0.60–0.89, specificity = 0.76, 95% CI = 0.60–0.87) to detect anxiety disorders in clinical samples. The GAI-20 was the most studied tool and had adequate sensitivity while maintaining acceptable specificity when identifying GAD and anxiety disorders. The GAI-20, GAI-Short Form and HADS-A tools are supported for use in detecting anxiety in community-dwelling older adults. Brief, self-rated and easy-to-use tools may be the best options for anxiety detection in community-dwelling older adults given resource limitations. Clinicians may consider factors including patient comorbidities and anxiety prevalence when selecting a tool and cut off.
- 4 September 2023
- Published by Cambridge University Press (CUP) in Canadian Journal on Aging / La Revue canadienne du vieillissement
- Vol. 43 (1) , 57-74
Understanding the Barriers to and Facilitators of Anxiety Management in Residents of Long-Term Care
Older adults, 65 years of age and older, living in long-term care (LTC) commonly experience anxiety. This study aimed to understand care providers’ perspectives on the barriers to and facilitators of managing anxiety in residents of LTC. Ten semi-structured interviews with care providers in LTC were completed. Framework analysis methods were used to code, thematically analyze, designate codes as barriers or facilitators, and map the codes to the Theoretical Domains Framework. Themes were categorized as acting at the resident, provider, or system level, and were labelled as either barriers to or facilitators of anxiety care. Key barriers to anxiety care at each level were resident cognitive impairment or co-morbidities; lack of staff education, staff treatment uptake and implementation; as well as the care delivery environment and access to resources. There is a need to prioritize measurement-based care for anxiety, have increased access to non-pharmacological treatments, and have a care delivery environment that supports anxiety management to improve the care for anxiety that is delivered to residents.
- 4 September 2023
- Published by Cambridge University Press (CUP) in Canadian Journal on Aging / La Revue canadienne du vieillissement
- Vol. 43 (1) , 57-74
Understanding the Barriers to and Facilitators of Anxiety Management in Residents of Long-Term Care
Older adults, 65 years of age and older, living in long-term care (LTC) commonly experience anxiety. This study aimed to understand care providers’ perspectives on the barriers to and facilitators of managing anxiety in residents of LTC. Ten semi-structured interviews with care providers in LTC were completed. Framework analysis methods were used to code, thematically analyze, designate codes as barriers or facilitators, and map the codes to the Theoretical Domains Framework. Themes were categorized as acting at the resident, provider, or system level, and were labelled as either barriers to or facilitators of anxiety care. Key barriers to anxiety care at each level were resident cognitive impairment or co-morbidities; lack of staff education, staff treatment uptake and implementation; as well as the care delivery environment and access to resources. There is a need to prioritize measurement-based care for anxiety, have increased access to non-pharmacological treatments, and have a care delivery environment that supports anxiety management to improve the care for anxiety that is delivered to residents.
- 2 September 2022
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 51 (9)
Non-pharmacologic and pharmacologic treatments for anxiety in long-term care: a systematic review and meta-analysis
Older adults living in long-term care (LTC) commonly suffer from anxiety symptoms and disorders. We completed a systematic review and meta-analysis to identify efficacious treatments for anxiety symptoms for older adults living in LTC. we searched five electronic databases (MEDLINE, Embase, PsycINFO, Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials) to identify treatments for anxiety that have been trialled in LTC. Included studies had to be randomised trials, include residents of LTC, and measure anxiety symptoms as an outcome. the electronic search returned 6,617 articles, 519 were reviewed in full text, and 80 were included in the descriptive synthesis. Limited studies were meta-analysed (n = 10) due to differences in described treatment and comparator conditions. Limited clinically relevant evidence supporting the use of pharmacologic treatments for symptoms of anxiety in LTC was identified. Of the treatments trialled, music compared with usual care (standardised mean difference, SMD: −0.82; 95% confidence interval (CI): −1.31, −0.34), music compared with social interaction (SMD: −0.41; 95% CI: −0.72, −0.10) and massage compared with usual care (SMD: −4.32; 95% CI: −7.44, −1.19) were found to improve anxiety symptoms, however, significant heterogeneity was detected in two comparisons. a range of non-pharmacologic treatments that improved anxiety symptoms were identified for use in LTC. Although limited evidence exists to support the use of particular treatments, most non-pharmacologic treatments were low-risk interventions that may be readily implemented. Further research is required to assess the treatment effect on residents of LTC with anxiety disorders or clinically relevant symptoms at baseline.
- 2 September 2022
- Published by Oxford University Press (OUP) in Age and Ageing
- Vol. 51 (9)
Non-pharmacologic and pharmacologic treatments for anxiety in long-term care: a systematic review and meta-analysis
Older adults living in long-term care (LTC) commonly suffer from anxiety symptoms and disorders. We completed a systematic review and meta-analysis to identify efficacious treatments for anxiety symptoms for older adults living in LTC. we searched five electronic databases (MEDLINE, Embase, PsycINFO, Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials) to identify treatments for anxiety that have been trialled in LTC. Included studies had to be randomised trials, include residents of LTC, and measure anxiety symptoms as an outcome. the electronic search returned 6,617 articles, 519 were reviewed in full text, and 80 were included in the descriptive synthesis. Limited studies were meta-analysed (n = 10) due to differences in described treatment and comparator conditions. Limited clinically relevant evidence supporting the use of pharmacologic treatments for symptoms of anxiety in LTC was identified. Of the treatments trialled, music compared with usual care (standardised mean difference, SMD: −0.82; 95% confidence interval (CI): −1.31, −0.34), music compared with social interaction (SMD: −0.41; 95% CI: −0.72, −0.10) and massage compared with usual care (SMD: −4.32; 95% CI: −7.44, −1.19) were found to improve anxiety symptoms, however, significant heterogeneity was detected in two comparisons. a range of non-pharmacologic treatments that improved anxiety symptoms were identified for use in LTC. Although limited evidence exists to support the use of particular treatments, most non-pharmacologic treatments were low-risk interventions that may be readily implemented. Further research is required to assess the treatment effect on residents of LTC with anxiety disorders or clinically relevant symptoms at baseline.
- Open Access
- 6 June 2022
- Published by Cambridge University Press (CUP) in Canadian Journal on Aging / La Revue canadienne du vieillissement
- Vol. 42 (1) , 92-101
Detecting Anxiety in Long-Term Care Residents: A Systematic Review
Anxiety is common in long-term care (LTC), but it is unclear which anxiety detection tools are accurate when compared to a reference standard for residents of LTC. Four databases and grey literature sources were searched using the search concepts “anxiety” and “LTC”. Included studies evaluated the diagnostic accuracy of an anxiety detection tool compared to a reference standard in LTC residents. Diagnostic accuracy measures were extracted. Four articles out of 4,620 met the inclusion criteria. Despite limited evidence and poorly reported study procedures and characteristics, the Geriatric Anxiety Inventory (sensitivity: 90.0%, specificity: 86.2%) and the Hospital Anxiety and Depression Scale-Anxiety (sensitivity: 90.0%, specificity: 80.6%) had the best performance when detecting generalized anxiety disorder. We identified four anxiety detection tools appropriate for use in LTC; a critical first step to diagnosing and managing anxiety in residents of LTC. Non-generalized anxiety disorders and tool feasibility must be further evaluated.
- 6 June 2022
- Published by Cambridge University Press (CUP) in Canadian Journal on Aging / La Revue canadienne du vieillissement
- Vol. 42 (1) , 92-101
Open AccessDetecting Anxiety in Long-Term Care Residents: A Systematic Review
Anxiety is common in long-term care (LTC), but it is unclear which anxiety detection tools are accurate when compared to a reference standard for residents of LTC. Four databases and grey literature sources were searched using the search concepts “anxiety” and “LTC”. Included studies evaluated the diagnostic accuracy of an anxiety detection tool compared to a reference standard in LTC residents. Diagnostic accuracy measures were extracted. Four articles out of 4,620 met the inclusion criteria. Despite limited evidence and poorly reported study procedures and characteristics, the Geriatric Anxiety Inventory (sensitivity: 90.0%, specificity: 86.2%) and the Hospital Anxiety and Depression Scale-Anxiety (sensitivity: 90.0%, specificity: 80.6%) had the best performance when detecting generalized anxiety disorder. We identified four anxiety detection tools appropriate for use in LTC; a critical first step to diagnosing and managing anxiety in residents of LTC. Non-generalized anxiety disorders and tool feasibility must be further evaluated.